Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. - Wikidata - awgldk - TriplyDB

Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene.

Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene.

http://www.wikidata.org/entity/Q45530812

about

Pulmonary applications and toxicity of engineered nanoparticles Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?Chymotryptic specificity determinants in the 1.0 A structure of the zinc-inhibited human tissue kallikrein 7 Whole blood gene expression in infants with respiratory syncytial virus bronchiolitis Induction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine design Inhibition of Respiratory Syncytial Virus Infections With Morpholino Oligomers in Cell Cultures and in Mice Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial Virus Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences Human kallikrein-related peptidase 14 (KLK14) is a new activator component of the KLK proteolytic cascade. Possible function in seminal plasma and skin Respiratory syncytial virus NS1 protein colocalizes with mitochondrial antiviral signaling protein MAVS following infection MicroRNA regulation of human protease genes essential for influenza virus replication RNA interference for alpha-ENaC inhibits rat lung fluid absorption in vivo 12R-lipoxygenase deficiency disrupts epidermal barrier function Impaired spermatogenesis and fertility in mice carrying a mutation in the Spink2 gene expressed predominantly in testes The interactome of the human respiratory syncytial virus NS1 protein highlights multiple effects on host cell biology Nanodelivery in airway diseases: challenges and therapeutic applications.Kallikrein-related peptidase-8 (KLK8) is an active serine protease in human epidermis and sweat and is involved in a skin barrier proteolytic cascade.Pharmacologic advances in the treatment and prevention of respiratory syncytial virus.Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections.Involvement of activation of PKR in HBx-siRNA-mediated innate immune effects on HBV inhibition.Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosis Live-cell characterization and analysis of a clinical isolate of bovine respiratory syncytial virus, using molecular beacons.The infectious march: the complex interaction between microbes and the immune system in asthma.Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo.Plasmid-encoded NP73-102 modulates atrial natriuretic peptide receptor signaling and plays a critical role in inducing tolerogenic dendritic cells.Kallikrein-5 promotes cleavage of desmoglein-1 and loss of cell-cell cohesion in oral squamous cell carcinoma.Combined fluticasone propionate and salmeterol reduces RSV infection more effectively than either of them alone in allergen-sensitized mice.Hair follicular expression and function of group X secreted phospholipase A2 in mouse skin.Possibilities for RNA interference in developing hepatitis C virus therapeutics.Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years Chitosan-DNA nanoparticles delivered by intrabiliary infusion enhance liver-targeted gene delivery Protein-Protein Interactions of Viroporins in Coronaviruses and Paramyxoviruses: New Targets for Antivirals?Nanotechnology Applications to HIV Vaccines and Microbicides.Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes.siRNA against the G gene of human metapneumovirus.Efficient inhibition of HIV-1 replication by an artificial polycistronic miRNA construct.Information technologies for vaccine research.Respiratory Syncytial Virus Nonstructural Proteins Upregulate SOCS1 and SOCS3 in the Different Manner from Endogenous IFN Signaling.

P2860

Q24650775-4E465DD4-3A1E-4D58-8A6B-6FEE67E98089 Q24669624-05F1B419-4630-439C-9528-A63D087E5059 Q24674282-3F3D8771-3383-43EF-8F3C-7B5CD85086A3 Q24679785-3630E855-6E17-43E6-ACBC-672203D051F6 Q27021304-1896A362-9E30-4E43-9CC9-6D1AA496261A Q27490424-D5B23CEC-BC43-4A59-900A-CED787ACE7E7 Q28067143-9F71BE43-E51F-46D1-8F0F-B4F941CC6F7B Q28243373-E4D642F3-596A-4129-9A8E-ACF3B52FD147 Q28259758-54D5C917-179C-4536-90DA-D25CF449E07C Q28481271-06C0C7D5-500B-4461-8FA7-0E69D1EFD743 Q28483683-7E6B9D95-68CA-424D-A424-6A7808BEBB35 Q28572413-A8B48CAC-300B-4E93-A59A-CFE1D1BB7EA9 Q28585387-EF5A0D8F-C941-4DBB-AD59-346F4158CDBA Q28593778-85DC5476-54A5-4738-9516-22881B5423BF Q28728377-D1C545A2-E273-4C12-9B4D-6B37BB53F4EA Q33483926-07FDB6C7-90DC-40E1-A886-95C7FA48A174 Q33715944-7AD2C48C-D507-4BB7-B447-066FF0A8C349 Q33776507-DD50959C-CA26-4B34-A95F-E4619DB9644B Q33883942-FC72E5C2-E235-4D11-ADD1-8791FD434446 Q33886159-6599FD1C-C505-4418-90A5-EBC348A84AA8 Q33911955-72A0B41A-D267-478B-B7B9-70736348BB6B Q34102905-CB5EB01B-FA26-490B-B500-347E3C2DC9A0 Q34198852-C4FAFDB9-D5DB-43AA-AF7B-223C63D13DAE Q34301714-498B92A3-4CBF-4930-BE05-3E59C8B0E89B Q34356430-5986594D-122D-4AA1-A8CC-091A1BEC85C6 Q34496721-D8D97F83-BEAF-49A8-B851-478E8DC55BDC Q34515184-76ADB9C0-7603-448C-87F6-57B1C2FF0A01 Q34685425-6428C731-79C6-43CC-B472-1E70C35A90BC Q34715945-9752C7D9-35B3-4CF7-974E-B6CE29C11A52 Q34719753-394F2AEC-29AE-48C0-990B-9415CF37E457 Q35261143-7BFF0E59-E6AA-4ED2-8A1C-50A30404EC51 Q35566601-F5B5BB82-2C25-4A47-BD2A-BC7A6433F25A Q35688220-20C5B487-8D15-40F6-8E61-924B9EC30340 Q35808644-C8C49038-E65B-44F7-BB85-333C154F32A6 Q35890514-F8CDC3EA-A905-4536-98BC-EE1C9B677B7B Q35928850-9E0A3282-9F97-41D9-8D99-EA9B7A4CE446 Q36086887-56ED1150-1E9C-4FE4-BD97-F3C1B41C7160 Q36156552-3EE52832-E321-48E4-A8B3-394360374416 Q36198676-84F05892-DAE6-4C7A-A150-4395AD413336 Q36236235-4381EB6F-2566-439C-8274-FAB776FD8EAA

P2860

Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene.

http://www.wikidata.org/entity/Q45530812

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Inhibition of respiratory sync ...... targeting the viral NS1 gene.

@en

Inhibition of respiratory sync ...... targeting the viral NS1 gene.

@nl

type

label

Inhibition of respiratory sync ...... targeting the viral NS1 gene.

@en

Inhibition of respiratory sync ...... targeting the viral NS1 gene.

@nl

prefLabel

Inhibition of respiratory sync ...... targeting the viral NS1 gene.

@en

Inhibition of respiratory sync ...... targeting the viral NS1 gene.

@nl

P1433

Q45530812-58EA047C-F9D0-4C28-9033-1EB70FC66F93

P1476

Q45530812-011B8554-A0AA-4D18-9278-1C95999B7711

P2093

Q45530812-1004FCBC-3933-49B2-9FCA-F821C6CE0802

Q45530812-5200746D-B422-4582-BBA8-A33AF71BAF33

Q45530812-6135D44D-9992-4EB3-BC73-660834FDA7EB

Q45530812-65D14790-D85F-4B53-9934-9866B8D561EF

Q45530812-7679D1F2-A7CC-49C3-9C32-963B047CD18E

Q45530812-8F850E25-D49E-4E03-BF28-D39A3523F9AE

Q45530812-91F96292-E9E8-4829-A407-A42A7F68FE17

Q45530812-976BA983-D84F-4972-A0DA-C42062F226DB

Q45530812-AD841BC0-D445-4CBB-9607-651BF9B3C5CB

Q45530812-B2E15CA1-D3F2-46DC-A2A6-625C44DF2D5B

P2860

Q45530812-030C4ECB-E568-4C61-A489-E2019B145FCF

Q45530812-04082536-8C64-4500-9154-81A1AC174D49

Q45530812-04ECDA1B-D2D9-462D-83C0-E2B9D44C9309

Q45530812-0B42601A-F2CF-45EF-92AA-4AD140D821BD

Q45530812-1522F64A-7DBA-4578-825A-46FD60437B81

Q45530812-17803F9D-7373-4C2C-8C42-BACA8421D43C

Q45530812-17CB921E-D530-42E1-859B-CF9D9973C2A8

Q45530812-18D42225-A2AA-4B34-BB42-45DAE872CE92

Q45530812-22D4B9C2-29E5-4C84-A0F4-7D056CB039EE

Q45530812-27B11047-D43C-4A31-BAF4-7D0855FCEAAC

P2888

Q45530812-99F82685-C1C5-4707-9CCF-93A7DC269E72

P304

Q45530812-14B0D75E-F983-42AC-9D5E-0C914B2A4D1A

P31

Q45530812-FBA30B83-004D-40AF-8055-18B1560EC679

P356

Q45530812-B81789DA-6538-4A39-A31D-982480799504

P407

Q45530812-9A94F13F-6F8E-413F-8D57-3EF1649CC7D6

P433

Q45530812-21F844F4-1602-4641-8DE8-F4CBBB1FC808

P478

Q45530812-905830E7-1BAE-4500-9FBB-087A62C5DF37

P577

Q45530812-1ACFC0EE-8159-415C-898F-C06BC7BDA233

P5875

Q45530812-5C13457C-E1B8-4077-A4F8-B1B43396103A

P6179

Q45530812-BD865C9F-37D5-408D-9B9A-2BFA7440B913

P698

Q45530812-A99DF02B-9905-4F78-8F6E-683059455C56

P921

Q45530812-138C586E-48AA-402B-B7D7-AE6277FF830C

P356

P1433

Nature Medicine

P1476

Inhibition of respiratory sync ...... targeting the viral NS1 gene.

@en

P2093

Gary Hellermann

http://www.w3.org/2001/XMLSchema#string

Homero San Juan-Vergara

http://www.w3.org/2001/XMLSchema#string

Hong Yang

http://www.w3.org/2001/XMLSchema#string

Rajeswari Singam

http://www.w3.org/2001/XMLSchema#string

Richard F Lockey

http://www.w3.org/2001/XMLSchema#string

Shyam S Mohapatra

http://www.w3.org/2001/XMLSchema#string

Subhra Mohapatra

http://www.w3.org/2001/XMLSchema#string

Sumita Behera

http://www.w3.org/2001/XMLSchema#string

Weidong Zhang

http://www.w3.org/2001/XMLSchema#string

Xiaoyuan Kong

http://www.w3.org/2001/XMLSchema#string

P2860

Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes

How cells respond to interferons

Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection

On the role of IRF in host defense

Mortality associated with influenza and respiratory syncytial virus in the United States

Activation of the interferon system by short-interfering RNAs

Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees

RNA-triggered gene silencing.

Specific interference with gene expression induced by long, double-stranded RNA in mouse embryonal teratocarcinoma cell lines.

Pathogenesis of RSV lower respiratory tract infection: implications for vaccine development.

P2888

P304

56-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM1174

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2004-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8110314

http://www.w3.org/2001/XMLSchema#string

P6179

1042953105

http://www.w3.org/2001/XMLSchema#string

P698

15619625

http://www.w3.org/2001/XMLSchema#string

P921